This is a cross-sectional study using data collected by the South and West Regional CF Database in England for the year 2002. This database is regionally funded, and covers a geographically defined population, which includes approximately 10% of the UK CF population, estimated at 9000 CF cases. The rate of acquisition of the database for essential data including age, gender, FEV 1 , diabetes, Pa infection, rate of IV antibiotics and body mass index (BMI) is over 94%. Aggregated data Background: Pulmonary exacerbations (P Exs) are important in cystic fibrosis (CF). They are very common, and are associated with poor quality of life. P Exs are regarded as an important end point in clinical trials. Risk factors associated with increase in P Exs have not been examined at a large scale. This study investigates factors associated with P Exs in a large cohort of adolescent and adult patients. Patients and methods: This is a cross-sectional study on data collected in the South and West Regions in England in 2002. Patients aged 16 years and over were included. Data on age, gender, FEV 1 , body mass index (BMI), infection with Pseudomonas aeruginosa (Pa) and on CF-related diabetes were included in the analysis. P Ex was defined as an episode treated with IV antibiotics. Forward stepwise multiple regression analysis was performed with the number of P Exs being the independent variable. The rest of the variables were considered to be the dependent variables. Results: Data from 341 patients (194 female), mean age (SD), 24.9 (8.9) years were available. In 2002, a total of 599 P Exs were reported, median 1.00 range 0-16 P Exs. Using stepwise multiple regression analysis factors associated with increased number of P Exs were: infection with Pa (t-value -5.0, P Ͻ 0.0001), FEV 1 , (t-value -4.9, P Ͻ 0.0001) and diabetes mellitus, (t-value -2.1, P ϭ 0.04). Age, gender and BMI did not influence the annual number of exacerbations. Conclusions: In this study, risk factors for P Exs were found to be as follows: growth of Pa in the sputum, reduced FEV1 and CF-related diabetes mellitus. Chronic Respiratory Disease 2008; 5: [29] [30] [31] [32] [33] 
Introduction
Pulmonary exacerbations (P Exs) are a prominent feature in the natural history of CF lung disease. 1, 2 They are an important reason for mortality 3 and morbidity 4 in CF patients. Number of P Exs is associated with an accelerated decline in the FEV 1 . 5 Frequency of P Exs and time until next P Ex are frequently identified as an outcome measure in clinical trials. [6] [7] [8] [9] Several studies have demonstrated that there are variations in what physicians regard as an exacerbation, with the difference being most marked between paediatric and adult CF physicians. [10] [11] [12] [13] Nevertheless, P Exs stand out as one of the several key issues that clinicians could impact with preventative and therapeutic strategies. Prevention of P Ex is an important goal in management of CF. It is, therefore, important to identify factors associated with increased P Exs in CF patients.
One recent study looked into risk of P Exs, but confined the research to a cohort of patients infected with multi-drug resistant Pa. 14 To our knowledge there are no large scale studies addressing risk factors associated with increased P Exs in adult CF patients who were not selected according to their sputum microbiology. This analysis is designed to address risk factors for increased P Exs in adult CF patients in a welldefined patient cohort in our geographical area. and data by individual unit on the number of patients and principle measures of outcome of care are published annually. A comparison of data from each unit with national or international data, where available, is also performed at the request of the unit.
Data on a total of 826 CF patients of all ages were available at the end of the study year, 2002. For the purpose of this study, our inclusion criteria were: patients aged 16 years or more in whom data on at least age, gender, number of exacerbations, FEV 1 and BMI were available. Patients who did not fulfil these criteria were excluded from the analysis. The age cut was loosely selected as being an adult age and because of our reported observation 13 that Ͻ10% of adult patients in the Southwest region received elective intravenous antibiotics. For the purpose of this analysis, data collected were age, gender, BMI, FEV 1 expressed as percentage of predicted values for age, sex and height, infection with Pa and diabetes mellitus. FEV 1 and BMI included in the database were the best values recorded during stability (away from exacerbations) for that year. Infection with Pa was considered present if they were cultured at least twice in the sputum within that year. CF-related diabetes for each patient was considered to be present if the physician caring for patients regarded the patient as diabetic. All patients are screened for diabetes at least on annual basis. Further screening is performed when clinically indicated. (weight loss, frequent P Exs, excessive thirst and polyurea etc). The policy in the Southwest region of England is that CF patients would be considered to be diabetic if both the oral glucose tolerance test was in the diabetic range (over 11.1 mmol/L after 120 min) and/or abnormal diabetic control on home blood glucose diary.
As in previous studies, 2,8,9 a P Ex was pragmatically considered to be present when an intravenous course of antibiotics was given. Our data registry, as it currently stands, does not identify the reason for each individual course of IV antibiotics; neither can it identify the site where antibiotics were provided (hospital or home). It is possible that few courses might have been provided for reasons other than P Exs, but if we applied the experience in our own centre, 98% of IV courses of antibiotics would be given for P Exs. We were less concerned with the number of elective courses of antibiotics as we knew from sub-analysis of a previously published survey that the rate of elective IV antibiotics in adult units was less than 10% (range 0-10%) throughout our region. 13
Statistical analysis
Statistical analysis was done with the assistance of the Medical Statistics Unit at Bristol Royal Infirmary.
Data was analysed using GB-STAT package for Windows and Graph Pad-Prism 4 package. Initial inspection of the data graphically and statistically was performed for normality of distribution. Data for age, FEV 1 and BMI were normally distributed. As the data for number of P Exs were not normally distributed (Figure 1 ), Spearman's rank correlation co-efficient test was initially used to examine the relationship between the number of P Exs and every individual continuous variable (FEV 1 , age and BMI). Frequency of P Exs according to categorical data (gender, growth of Pa status and diabetic status) was compared using Mann-Whitney U test. Analysis of difference in the mean of age, BMI and FEV 1 according to the frequency of Pa status and presence or absence of CF related diabetes were done using unpaired t-tailed test analysis.
It was obvious that the closest relationship with number of P Exs was the growth of Pa in the sputum and FEV 1 . The contribution of other confounding variables was examined by using a forward stepwise multiple regression analysis with the number of P Exs remaining the independent variable.
Results
The south and west of England database had data on 826 CF patients for 2002. Of these, 399 patients were aged 16 years or more. Data on 341 (85%) fulfilled all aspects of our inclusion criteria ( Table 1) ; out of those there was 147 female. The mean age of patients included in the analysis was 24.9 years, range (16-64 years) and mean FEV 1 65.8, range 11-133% of predicted values. 
The influence of gender
There was no difference between female and male CF patients with regards to age, FEV 1 , BMI, rate of CF-RD and rate of Pa infection ( Table 2) .
Pseudomonas aeruginosa
Data on Pa were available on 341 (100%) patients. Of these, 231 (68%) grew Pa in their sputa that year and were regarded as infected. There was no difference in the mean age of patients who were infected with Pa (25.1 years) and those who were not (25.5 years).
Patients who were infected with Pa had a reduced BMI values, mean 20.8 kg/m 2 compared to those who were not, mean BMI 22.1, (P Ͻ 0.001). Similarly the value of FEV 1 was reduced in infected patients compared with those who were not, 62.0 and 73.9% predicted, respectively P Ͻ 0.0001.
CF-related diabetes mellitus (CF-RD)
Data on CF-RD status was available on 340 patients (99.7%) of patients. Of those 78 patients (22.9%) were diabetics. There was no difference in median age between patients with and without CF-RD 25.5 and 24.5 years, respectively. BMI also did not differ between the two groups 20.8 and 21.3 kg/m 2 respectively. FEV 1 was reduced in patients with CF-RD compared to those without 59.4% predicted and 67.7% predicted respectively, P Ͻ 0.02.
Body mass index
Data for BMI were available on 322 (94%) of patients. BMI values correlated with FEV 1 , r ϭ ϩ0.39, P Ͻ 0.0001 and with age, r ϭ ϩ0.22, P Ͻ 0.0001.
Pulmonary exacerbations
In 2002, there were a total of 599 P Exs in the 341 CF patients included in this analysis. Mean number of annual P Exs was 1.5, median 1.0 and range 0-16 P Exs.
No P Exs were reported on 129 patients (38%). Eightysix patients (25.3%) had three or more P Exs. Figure 1 , shows the histogram of annual frequency of P Exs. Results of stepwise multiple regression analysis are shown in Table 3 . The most influential factors on the number of P Exs were infection with Pa, followed by FEV 1 and then diabetes status. Age, gender and BMI did not contribute to the increase in number of P Exs.
Discussion
Despite the importance of CF P Exs in both clinical, economical 15 and research settings there are no agreed criteria on the definition. Probably because of this, there has been no large-scale studies on factors associated with increased P Exs.
In a recent study, the number of P Exs was found to increase in patients with reduced FEV 1 and greater treatment burden and in whom there were increase in P Exs prior to entering the study. 14 This analysis was performed on a group of CF patients whom, by their inclusion criteria, had had multiple drug resistance Pa.
To our knowledge, our study is the largest analysis looking into risk factors of P Exs in adult patients. Our database does not stipulate the indication for IV antibiotics. We have nevertheless chosen courses of IV antibiotics as markers of P Exs. In our unit P Exs are by far the commonest indication for providing IV antibiotics in adult CF patients. We also believed that with the large number of patients, other reasons for providing IV antibiotics would be small. Data on younger CF patients were excluded to minimize the number of patients who would be given IV antibiotics electively. In a recent survey involving all CF units in the United Kingdom (published in an abstract form to date) 13 we found that paediatric CF physicians gave elective IV antibiotics to twice of the proportion of their CF patients than the adult CF physicians. A subanalysis on the data in the Southwest region found that adult units provide elective antibiotics to less than 10% (range 0-10%) of patients.
As expected, annual P Exs increased in patients with reduced FEV 1 . This is similar to findings reported in the study by Block et al. 14 and in respiratory diseases other than CF. 15, 16, 17 It is not possible in a crosssectional analysis to establish whether the relationship between P Exs and reduced FEV 1 is a cause or an effect, although in previous longitudinal studies it was shown that the number of exacerbations was associated with accelerated decline in FEV 1 . 5, 18 It would therefore seem logical that the relationship between the two factors might represent a 'vicious circle'.
We found that the strongest factor associated with the number of P Exs was isolation of Pa in the sputum. This adds to the multitude of harmful effect of chronic infection of Pa which was found to be associated with reduced FEV 1 and BMI [19] [20] [21] and increased mortality rate [21] [22] [23] in CF patients.
It has already been established that a decline in both nutritional status and FEV 1 is typical in the years leading to this diagnosis and in untreated diabetic patients. [24] [25] [26] [27] [28] The finding of our analysis complemented these studies by showing that CF-RD was associated with increased P Exs despite the fact that diabetic patients in the South West of England almost invariably received treatment for their diabetes once diagnosed.
To our surprise, reduced BMI was not associated with increase in P Exs in this study after accounting to other confounders by multiple regression analysis. The reason for this is not immediately clear. This is similar to the finding of the study by Block et al. 14 To our knowledge there have been no other previous studies examining whether reduced BMI was an independent factor in increased number of P Exs although reduced BMI has been found to be associated with reduced FEV 1 and increased mortality. 5, 29, 30 Our study found an association between risk factors and frequency of P Exs rather than a causation of P Exs in the conventional sense.
The results of our analysis are in variance to a previous work published by Rabin et al. 31 who found that P Ex's in young CF patients increased with age. This is probably due to difference in spectrum of age between the two studies. Like our study, rate of P Exs was greater in patients with reduced FEV 1 .
A recent review article by Goss et al. found that studies demonstrated a close association between poor lung function and the rate of P Exs that needed hospitalization and needing IV antibiotics. 32 The relationship for adult CF was linear but for the paediatric population the relationship was non-linear.
We recognize that there are many shortfalls with studies based on data obtained from registries, mainly in areas of accuracy of recording data and differences in reporting. In this study there were over 85% of data acquisitions for most of essential variables. In addition we would expect that the large number of patients would compensate for the shortfall of collecting data in a registry environment.
Prevention of P Exs is a major goal of the CF community. This study gives more reasons for a more effective long-term management for chronic infection with Pa and CF-related diabetes mellitus especially in patients with reduced FEV 1 .
Conflict of interest:
None.
